BridgeBio Pharma Inc. (2CL)
FSX
Real-time Data
06:00 AM
Day's Range
59.1652 wk Range
45.40Overview - 2CL - BridgeBio Pharma Inc.
Key Statistics
Valuation
Enterprise Value
12.63B
P/E (Trailing)
‪-15.07‬
P/E (Forward)
‪-15.91‬
PEG Ratio
‪0.84‬
Price / Sales (TTM)
‪15.61‬
Price / Book
‪-4.45‬
EV / EBITDA
‪-30.50‬
Profitability
Gross Margin
‪93.82%‬
Profit Margin
‪-97.02%‬
Operating Margin
‪-43.94%‬
Return on Assets
‪-25.99%‬
Return on Equity
‪34.90%‬
Ownership
Shares Outstanding
195.28M
Float
167.19M
Held by Insiders
‪3.91%‬
Held by Institutions
‪99.68%‬
Price stats
Beta
‪0.97‬
50-Day Avg
‪67.55‬
200-Day Avg
‪62.99‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 2CL - BridgeBio Pharma Inc.
Peers - 2CL - BridgeBio Pharma Inc.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- 2CLFSXBridgeBio Pharma, Inc.11.13BMarket Cap+27.08%52-week change-15.07P/E (Trailing)‪-97.02%‬Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)‪29.78%‬Profit Margin
- 0QFFSXModerna Inc.69.12BMarket Cap+87.76%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 64BFSXAstera Labs, Inc.53.43BMarket Cap+42.53%52-week change179.66P/E (Trailing)‪30.74%‬Profit Margin
- 1AEFSXargenx SE52.63BMarket Cap+28.29%52-week change36.62P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt50.36BMarket Cap+25.47%52-week change34.88P/E (Trailing)‪32.26%‬Profit Margin
- 42ZFSXRevolution Medicines, Inc.37.58BMarket Cap+78.78%52-week change-29.47P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - 2CL - BridgeBio Pharma Inc.
About
BridgeBio Pharma, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for patients with genetic diseases and genetically driven cancers. The company concentrates on conditions with well-defined genetic causes, aiming to design targeted therapies that address the underlying…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
